Physiol. Genomics Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (March 17, 2009). doi:10.1152/physiolgenomics.90407.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/3/249    most recent
90407.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koks, S.
Right arrow Articles by Schalkwyk, L. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koks, S.
Right arrow Articles by Schalkwyk, L. C
Submitted on December 26, 2008
Revised on March 3, 2009
Accepted on March 10, 2009

Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway

Sulev Koks1*, Ursel Soomets1, Jose Paya-Cano2, Cathy Fernandes2, Hendrik Luuk1, Mario Plaas1, Anton Terasmaa1, Vallo Tillmann1, Klari Noormets1, Eero Vasar1, and Leo C Schalkwyk2

1 University of Tartu
2 King's College London

* To whom correspondence should be addressed. E-mail: Sulev.Koks{at}ut.ee.

The aim of present study was to describe changes in gene expression in the temporal lobe of mice induced by deletion of the Wfs1 gene. Temporal lobes samples were analyzed using Affymetrix Mouse Genome 420 2 Genechips and expression profiles were functionally annotated using GSEA and Ingenuity Pathway Analysis. We found that Wfs1 mutant mice are significantly smaller (20.9 ± 1.6 g) than their wild-type counterparts (31.0 ± 0.6g, p < 0.0001). This difference existed in 129S6 and C57B6 backgrounds. Interestingly, microarray analysis identified upregulation of growth hormone (GH) transcripts and functional analysis revealed activation of GH pathways. In line with microarray data, the level of IGF-1 in the plasma of Wfs1 mutant mice was significantly increased (p < 0.05). Thus, Wfs1 deletion induces growth retardation whereas the GH pathway is activated. In order to test the interaction between the Wfs1 deletion and genomic background, mutant mice were backcrossed to two different genetic backgrounds. In line with previous studies, an interaction between a gene knockout and genetic background was found in gene expression profiles in the congenic region. However, genetic background did not alter the effect of the Wfs1 mutation on either body weight or GH pathway activation. Further studies are needed to describe biochemical and molecular changes of the growth hormone axis as well as in other hormones to clarify their role in growth retardation in the Wfs1 mutant mice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.